Moderna COVID-19 vaccine spurs lasting immune response
Immune system memory stays strong 6+ months post-vaccination, similar to responses in recovered COVID-19 patients
What you need to know about variants, vaccines, and breakthrough COVID cases
Can we stretch existing Covid vaccines to inoculate more people? Experts are divided
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
In-Depth: La Jolla Institute takes comprehensive look at COVID-19 immunity
Study compares four vaccines and natural immunity
LJI and Synbal, Inc. partner to develop better COVID-19 models
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
A COVID-fighter’s guide to T cells
New LJI review shows how T cells target more than 1,400 sites on SARS-CoV-2
The new CEO of the La Jolla Institute for Immunology ascended by lifting others
Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
Learning from men. Learning from women.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
Tempus dare: A time to give
San Diego biotech entrepreneurs François Ferré, Ph.D., and Magda Marquet, Ph.D., knew supporting LJI would be critical for advancing our understanding of COVID-19.
